Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02747602 · ClinicalTrials.gov registry record · Phase 1
Evaluation of PK of AC1204 v Caprylic Triglyceride Oil Incl Food Effect on Ketone Body Production
A Phase 1 study, sponsored by Cerecin.
- Completed
- Registry status
- Phase 1
- Development phase
- 16
- Enrollment target
NCT02747602: Completed Phase 1 study, sponsored by Cerecin.
NCT02747602 is a Phase 1 study that has completed, run by Cerecin. The registered enrollment target is 16 participants, below the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (73% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02747602, a Phase 1 study, has completed, sponsored by Cerecin.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 16 participants
- Enrollment target
Study Summary
To compare serum ketone body (i.e., total ketones and β-hydroxybutyrate) levels after administration of AC-1204 versus caprylic triglyceride (CT) oil, both after a standard breakfast. To evaluate the effect of a high fat diet on serum ketone body levels after administration of CT oil with a high fat breakfast versus a standard breakfast.
Primary Outcome
The area under the concentration-time curve, from time 0 to the last observed non-zero concentration, as calculated by the linear trapezoidal method.
Interventions
- DRUG AC-1204
- DRUG caprylic triglyceride oil (standard breakfast)
- DRUG caprylic triglyceride oil (high fat breakfast)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 16 participants |
| Start Date | 2016-04 |
| Est. Completion | 2016-10 |
| Phase | Phase 1 |
What the finished NCT02747602 record still lists
NCT02747602 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 16 participants, a relatively small participant target, below the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (73% lower).
The record links to 0 conditions, and to 3 interventions - of which AC-1204 is the first listed.
NCT02747602 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02747602 about?
NCT02747602 is a clinical study titled "Evaluation of PK of AC1204 v Caprylic Triglyceride Oil Incl Food Effect on Ketone Body Production". To compare serum ketone body (i.e., total ketones and β-hydroxybutyrate) levels after administration of AC-1204 versus caprylic triglyceride (CT) oil, both after a standard breakfast. To evaluate the effect of a high fat diet on serum ketone body levels after administration of CT oil with a high fa...
What is the current status of trial NCT02747602?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 16 participants. The study started on 2016-04. Estimated completion is 2016-10.
What interventions are being tested in trial NCT02747602?
The interventions under investigation include: AC-1204 (DRUG), caprylic triglyceride oil (standard breakfast) (DRUG), caprylic triglyceride oil (high fat breakfast) (DRUG).
Who is sponsoring clinical trial NCT02747602?
This trial is sponsored by Cerecin, which has 11 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02747602's enrollment target sits among peer trials
16 1786th of 2000 higher than 203 of 2,000 other Phase 1 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 1 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02422641 · 16 participants · Phase 2
Prospective Evaluation Of High-Dose Systemic Methotrexate In Patients With Breast Cancer And Leptomeningeal Metastasis
- NCT02851758 · 16 participants · NA
Transplantation of Autologously Derived Mitochondria Following Ischemia
- NCT03291028 · 16 participants
Analysis of Primary and Metastatic Tumors in Patients With Renal Cell Carcinoma and Urothelial Carcinoma
- NCT03425526 · 16 participants · Phase 1
Donor T Cell Therapy in Treating Immunocompromised Patients With Adenovirus-Related Disease
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia